Long ‐term administration of intravenous inotropes in advanced heart failure

ConclusionIn-hospital continuous parenteral inotropic therapy may serve as a temporary pharmacological bridge to HTx in patients with advanced HF that are actively listed to HTx with good reply in terms of prognosis and perfusion markers.

Source: ESC Heart Failure - June 30, 2021 Category: Cardiology Authors: Piero Gentile, Claudia Marini, Enrico Ammirati, Enrico Perna, Gianluigi Saponara, Andrea Garascia, Luciana D'Angelo, Alessandro Verde, Grazia Foti, Gabriella Masciocco, Maria Frigerio, Manlio Cipriani Tags: Short Communication Source Type: research